Company · CIK 1718644
Zander Therapeutics, Inc
| CIK | 1718644 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | NV |
| Business address | CA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2018-09-26 |
Offerings
1 registration| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-220790 | 2017-10-04 | 2018-05-30 | 6 |
Filings
6| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2018-05-30 | EFFECTDeclared effective | 333-220790 | 9999999995-18-001374 |
| 2018-04-25 | S-1/AAmendment | 333-220790 | 0001607062-18-000140 |
| 2018-04-13 | S-1/AAmendment | 333-220790 | 0001607062-18-000117 |
| 2018-03-20 | S-1/AAmendment | 333-220790 | 0001607062-18-000086 |
| 2018-01-16 | S-1/AAmendment | 333-220790 | 0001607062-18-000021 |
| 2017-10-04 | S-1Registration filed | 333-220790 | 0001607062-17-000323 |